Cyclophil Me 50mg Capsule

Cyclophil Me 50mg Capsule is a systemic immunosuppressant medication containing cyclosporine as its active pharmaceutical ingredient. Manufactured by Biocon Limited, this potent immunomodulator works by selectively inhibiting T-lymphocyte activation, specifically blocking the transcription of interleukin-2 and other cytokines essential for immune response. This mechanism makes it invaluable in preventing organ rejection following kidney, liver, and heart transplantation, as well as managing bone marrow transplantation complications and severe rheumatoid arthritis unresponsive to conventional therapy. While categorized under eye care due to cyclosporine's ophthalmic applications in products like Cyclomune 0.05% Eye Drop, the 50mg capsule formulation serves primarily systemic immunosuppressive purposes rather than ocular conditions.

About Cyclophil Me 50mg Capsule

Cyclosporine belongs to a class of medications known as calcineurin inhibitors, which revolutionized transplant medicine when introduced in the 1980s. The drug achieves therapeutic immunosuppression by binding to cyclophilin, an intracellular protein, forming a complex that inhibits calcineurin phosphatase activity. This cascade prevents the dephosphorylation and nuclear translocation of nuclear factor of activated T-cells (NFAT), ultimately suppressing the production of inflammatory cytokines. Biocon Limited manufactures this formulation to exacting pharmaceutical standards, ensuring consistent bioavailability and therapeutic efficacy. Patients requiring different strengths may also consider Cyclodose 25mg Capsule or Cyclodose 50mg Capsule depending on their prescribed regimen and individual therapeutic needs.

Dosage & Usage

Dosing of Cyclophil Me 50mg must be individualized based on the specific indication, patient weight, and concurrent immunosuppressive therapy. For organ transplantation, initial doses typically range from 10-15 mg/kg daily, divided into two doses administered 12 hours apart, beginning 4-12 hours before transplantation. Maintenance doses are gradually reduced to 3-6 mg/kg daily based on therapeutic drug monitoring and clinical response. For rheumatoid arthritis, lower doses of 2.5-4 mg/kg daily are standard. The capsules should be taken consistently at the same times each day, preferably on an empty stomach or with food to maintain stable absorption patterns. Never exceed prescribed doses, as cyclosporine has a narrow therapeutic index requiring careful monitoring of blood levels, renal function, and blood pressure throughout treatment.

Who Is It For?

Cyclophil Me 50mg Capsule is prescribed for adult and pediatric transplant recipients requiring immunosuppression to prevent graft rejection, patients undergoing bone marrow transplantation to prevent graft-versus-host disease, and individuals with severe active rheumatoid arthritis inadequately controlled by methotrexate alone. This medication is contraindicated in patients with hypersensitivity to cyclosporine or any excipients, uncontrolled hypertension, uncontrolled infections, or malignancies except certain skin cancers. Pregnant women should use cyclosporine only when potential benefits justify fetal risks, and breastfeeding is not recommended during therapy. Patients with impaired renal function require dose adjustments and intensified monitoring, as nephrotoxicity represents a significant adverse effect requiring vigilant clinical oversight.

Why Buy From SafeRxPills?

SafeRxPills provides genuine WHO-GMP certified Cyclophil Me 50mg Capsules with discreet, secure shipping to the USA, UK, Australia, and Canada. Your medication arrives within 7-14 business days in plain, unmarked packaging that protects your privacy completely. We source exclusively from licensed manufacturers and maintain rigorous quality assurance protocols, ensuring you receive authentic immunosuppressant therapy at competitive prices. Our licensed pharmacy platform offers secure online ordering, professional customer support, and complete confidentiality for your transplant and autoimmune disease medication needs.